Wei Xin Lu

US Patent:

20090263485, Oct 22, 2009

Filed:

Mar 2, 2009

Appl. No.:

12/380680

Inventors:

Chun Li - Missouri City TX, US
Wei Lu - Houston TX, US
Marites P. Melancon - Houston TX, US
Chiyi Xiong - Cypress TX, US
Jason Stafford - Houston TX, US
Jin Z. Zhang - Santa Cruz CA, US

International Classification:

A61K 9/14
G01N 33/53
B32B 5/16
A61P 35/00

US Classification:

424489, 435 71, 428402, 977773, 977927

Abstract:

Provided are novel nanostructures comprising hollow nanospheres and nanotubes for use as chemical sensors and molecular specific photothermal coupling agents. The nanostructures can be used in laser-induced phototherapy for treatment of cancer and other disorders. The nanostructures can also be used as a sensor that detects molecules. The nanostructures are of particular use in the fields of clinical diagnosis, clinical therapy, clinical treatment, and clinical evaluation of various diseases and disorders, manufacture of compositions for use in the treatment of various diseases and disorders, for use in molecular biology, structural biology, cell biology, molecular switches, molecular circuits, and molecular computational devices, and the manufacture thereof. The hollow gold nanospheres have a unique combination of spherical shape, small size, and strong, tunable, and narrow surface plasmon resonance absorption covering the entire visible to near IR region.

US Patent:

20110190217, Aug 4, 2011

Filed:

Mar 28, 2011

Appl. No.:

13/073275

Inventors:

Bo Wang - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US
Peter C. Dowling - Fort Lee NJ, US

International Classification:

A61K 38/12
A61P 29/00
A61P 25/00
A61P 25/28
A61P 25/16
A61P 27/02
A61P 27/00
A61P 27/16

US Classification:

514 178, 514 177, 514 179

Abstract:

The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.

US Patent:

20120142111, Jun 7, 2012

Filed:

Jun 11, 2010

Appl. No.:

13/378440

Inventors:

James M. Tour - Bellaire TX, US
Dmitry Kosynkin - Houston TX, US
Michael Wong - Houston TX, US
Mason Tomson - Houston TX, US
Jacob Berlin - Houston TX, US
Ashley Leonard - Houston TX, US
Jay Lomeda - Houston TX, US
Wei Lu - Houston TX, US
Jie yu - Katy TX, US
Lunliang Zhang - Beijing, CN
Amy Kan - Houston TX, US

International Classification:

G01N 21/64
C07D 303/32
C07D 263/52
G01N 33/00
C09K 11/06
G01N 21/29
C07C 63/33
B82Y 15/00

US Classification:

436 27, 436 56, 436164, 549543, 562405, 548217, 2524081, 25230116, 428402, 73 5301, 977773

Abstract:

Compositions containing a transporter component and a signaling component and a method for using said compositions for analyzing porous media and flowing liquid streams, specifically for measuring pressure, temperature, relative abundance of water, pH, redox potential and electrolyte concentration. Analytes may include petroleum or other hydrophobic media, sulfur-containing compounds. The transporter component includes an amphiphilic nanomatenal and a plurality of solubilizing groups covalently bonded to the transporter component. The signaling component includes a plurality of reporter molecules associated with the transporter component. Said reporter molecules may be releasable from the transporter component upon exposure to at least one analyte. The reporter molecules may be non-covalently associated with the transporter component, or the reporter molecules are covalently bonded to the transporter component. Furthermore, said compositions and methods may be used to actively enhance oil recovery and for remediation of pollutants.

US Patent:

20220410750, Dec 29, 2022

Filed:

Jun 9, 2022

Appl. No.:

17/836986

Inventors:

- , US
Chi-Cheng Chu - Aliso Viejo CA, US
Yijing Jiang - Los Angeles CA, US
Wei Lu - Los Angeles CA, US
Weiheng Yuan - Yorba Linda CA, US
Jahnvi Ramachandran - Los Angeles CA, US
Liam Namba - Honolulu HI, US

International Classification:

B60L 53/62
B60L 53/67

Abstract:

The present invention provides an artificial intelligence-based system for management of electric vehicles fleet. The system receives live data and historical data feeds from charging stations, fleet telematics, meteorological services, traffic management, mobile application, fleet dashboard, renewable source of energy, battery energy storage system, and the electric utility grid. The system utilizes machine learning algorithms to predict energy usage and optimize the charging schedule of electric vehicle. The system uses real time data to generate electric vehicle trip condition training feature for predicting the remaining driving range. The system predicts the vehicle's arrival time at the charging station based on telematics data of each vehicle collected from the fleet management system.

US Patent:

20200376079, Dec 3, 2020

Filed:

Jun 5, 2020

Appl. No.:

16/894265

Inventors:

- Washington DC, US
Bo Wang - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US

International Classification:

A61K 38/18
A61K 38/12

Abstract:

The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.

US Patent:

20180303903, Oct 25, 2018

Filed:

Jul 2, 2018

Appl. No.:

16/025827

Inventors:

Peter C. Dowling - Fort Lee NJ, US
Bo Wang - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US

International Classification:

A61K 38/18
A61K 38/12
C07K 14/505

Abstract:

The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.

US Patent:

20170137483, May 18, 2017

Filed:

Jan 23, 2017

Appl. No.:

15/413398

Inventors:

Peter C. Dowling - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US

International Classification:

C07K 14/505

Abstract:

The described invention provides compositions having EPO-derived peptides, and methods and kits for administering the EPO-derived peptide to a subject suffering from a neurodegenerative disease or an inflammatory disease of the brain or spinal cord. The EPO-derived peptide delays the onset and/or progression of a neurodegenerative disease, limits cognitive impairment in, and prolongs the survival of, subjects suffering from a neurodegenerative disease or an inflammatory disease of the brain or spinal cord.

US Patent:

20170081441, Mar 23, 2017

Filed:

Sep 23, 2016

Appl. No.:

15/274085

Inventors:

James M. Tour - Bellaire TX, US
Wei Lu - Houston TX, US
Bostjan Genorio - Ivancna Gorica, SI

Assignee:

William Marsh Rice University - Houston TX

International Classification:

C08F 112/08
D01F 9/12
C07C 15/56
C07C 2/76
C07C 67/035
C07C 69/76

Abstract:

Embodiments of the present invention provide methods of preparing functionalized graphene nanoribbons by (1) exposing a plurality of carbon nanotubes to an alkali metal source in the presence of an aprotic solvent, wherein the exposing opens the carbon nanotubes; and (2) exposing the opened carbon nanotubes to an electrophile to form functionalized graphene nanoribbons. Such methods may also include a step of exposing the opened carbon nanotubes to a protic solvent in order to quench any reactive species on the opened carbon nanotubes. Further embodiments of the present invention pertain to graphene nanoribbons formed by the methods of the present invention. Additional embodiments of the present invention pertain to nanocomposites and fibers containing the aforementioned graphene nanoribbons.